middle.news
Memphasys Advances Global Commercial Scale-Up with Recurring Revenue Growth
1:32pm on Tuesday 7th of April, 2026 AEST
•
Healthcare
Read Story
Memphasys Advances Global Commercial Scale-Up with Recurring Revenue Growth
1:32pm on Tuesday 7th of April, 2026 AEST
Key Points
Multi-market revenue generation across Europe, MENA, Japan, and Australia
Recurring revenue model driven by single-use cartridge sales
Improved unit economics with target pricing and cost of goods sold
Regulatory approvals enabling rapid market expansion
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Memphasys (ASX:MEM)
OPEN ARTICLE